Arrowhead to Evaluate Agricultural, Pharmaceutical, Medical Technology and Resource Opportunities and Announces Financing

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 9, 2014) - Arrowhead Gold Corp. (the "Company") (TSX VENTURE:AWH) announces that it will be investigating additional company growth prospects. The new areas that will be examined will potentially include, but will not be limited to, agriculture, pharmaceutical, medical technology, and resources. At this time no new project has been anticipated and there is no surety that one will be completed.

CEO Steve Smith states "New and emerging markets in the agricultural, pharmaceutical and medical technology industry are poised for future growth; as these industries mature, so will the variety and depth of businesses within it."

The Company also announces a non-brokered private placement of up to eight million units for gross proceeds of up to $560,000. Each unit, at a price of 0.08 cents per unit, will consist of one common share and one-half of one, non-transferrable share purchase warrant. Each full warrant entitles the holder to purchase one common share at a price of 0.15 cents per share for a period of 24 months. The proceeds from the private placement will be used for acquisitions, investments and general working capital to advance the company's initiatives in the agriculture, pharmaceutical, medical technology, and resources industries. The private placement and any finder's fees payable are subject to regulatory approval. Any securities issued pursuant to the offering shall be subject to a four-month-and-a-day hold period commencing on the closing date.

On Behalf of the Board of Arrowhead Gold Corp.,

Steve Smith, President

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The Company disclaims any intention or obligation to revise or update such statements.